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Abstract The limitation of current dissociative fluores-
cence enhancement techniques is that the lanthanide chelate
structures used as molecular probes are not stable enough in
one-step assays with high concentrations of complexones or
metal ions in the reaction mixture since these substances
interfere with lanthanide chelate conjugated to the detector
molecule. Lanthanide chelates of diethylenetriaminepenta-
acetic acid (DTPA) are extremely stable, and we used
EuDTPA derivatives conjugated to antibodies as tracers in
one-step immunoassays containing high concentrations of
complexones or metal ions. Enhancement solutions based
on different β-diketones were developed and tested for their
fluorescence-enhancing capability in immunoassays with
EuDTPA-labelled antibodies. Characteristics tested were
fluorescence intensity, analytical sensitivity, kinetics of
complex formation and signal stability. Formation of
fluorescent complexes is fast (5 min) in the presented
enhancement solution with EuDTPA probes withstanding
strong complexones (ethylenediaminetetra acetate (EDTA)
up to 100 mM) or metal ions (up to 200 μM) in the reaction
mixture, the signal is intensive, stable for 4 h and the
analytical sensitivity with Eu is 40 fmol/L, Tb 130 fmol/L,
Sm 2.1 pmol/L and Dy 8.5 pmol/L. With the improved
fluorescence enhancement technique, EDTA and citrate
plasma samples as well as samples containing relatively
high concentrations of metal ions can be analysed using a
one-step immunoassay format also at elevated temper-
atures. It facilitates four-plexing, is based on one chelate
structure for detector molecule labelling and is suitable for
immunoassays due to the wide dynamic range and the
analytical sensitivity.
Keywords Time-resolved fluorometry.Dissociative
fluorescence enhancement.Immunoassay.Multiplexing.
Eu.Sm.Tb.Dy.Antibody
Introduction
Ions of the lanthanides Eu, Sm, Tb and to a lesser degree
Dy have successfully been exploited as labels in bioanalyt-
ical assay for the last two decades [1–3]. Of all the different
ways to apply lanthanide labels to bioanalytical assays, the
most common technique is the one which is based on non-
fluorescent lanthanide chelates [4, 5]. In this technique, the
ion is chelated to polyaminopolyacetic acids which in turn
are conjugated to the detector molecule. When the
bioaffinity reaction is completed, the lanthanide ions are
dissociated from the chelates on the detector molecule, into
a fluorescence-enhancing solution containing ligands that
form a fluorescent metal complex with the ions. Due to a
long fluorescence decay time and intensive fluorescence,
time-resolved fluorometry is the detection method of
choice, i.e. the fluorescence is measured after the back-
ground fluorescence has decayed. In this way, the auto-
fluorescence can be omitted resulting in ultimate analytical
sensitivity [4, 6]. This technique has been widely employed
in immunoassays, nucleic acid hybridisation assays,
receptor-ligand assays, enzyme activity measurements and
in various other applications [1, 6–8]. The physicochemical
properties of different enhancement solutions and chelates
have been discussed in several papers [5, 9, 10–12].
The lanthanide chelates attached to the detector
molecule must be stable enough to withstand the
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the lanthanide ion from the chelate. On the other hand,
the ion should be rapidly dissociated into the enhance-
ment solution before the fluorescence measurement;
otherwise, the technique is not fast enough for routine
laboratory applications and automation. Commercially
available dissociated-enhanced lanthanide fluorescent
immunoassay (DELFIA®) chelates and enhancement
solutions meet these criteria in that serum and plasma
samples not containing strong complexones can be used
whereas samples containing high concentrations of
complexones or metal ions should be avoided in one-
step assays. This is sometimes a limitation in the clinical
laboratory as blood is taken into both serum and plasma
tubes and thus there is a need for a technology that
works with all types of samples [13].
The aim of this study was to develop an enhancement
solution that quickly and efficiently dissociates lantha-
nide ions from chelates that are stable at harsh assay
condition involving strong complexones and heavy
metals. One-step assays with high concentrations of
citrate, ethylenediaminetetra acetate (EDTA) or metal
ions, require that the detector molecule is labelled with
an extremely stable lanthanide chelate. Such assays are
immunoassays based on citrate and EDTA plasma
samples, enzyme activity assays relying on high concen-
trations of metal ions in order for the enzyme to be
active, soil analysis with immunoassays, cytotoxicity
assays and nucleic acid assays carried out partly at
relatively high temperatures [7–10, 14].
Materials and methods
Reagents and buffers
Ten β-diketone molecules of the formula R1–C(=O)–CH2–
C(=O)–R2 where R1 was a naphthyl, benzofuryl, furyl or
thienyl group and R2 was an alkyl chain with two or three
carbon atoms substituted with five to seven fluorine atoms,
tri-n-octylphosphineoxide (TOPO), Eu (100 nmol/L), Sm
(10 μmol/L), Tb (100 nmol/L) and Dy (10 μmol/L)
standard solutions, isothiocyanate-activated diethylene-
triaminepentaacetic acid (DTPA) lanthanide chelates,
DELFIA® clear microtitration strip plates and DELFIA
enhancement solution were obtained from PerkinElmer
Inc. Anti-human chorionic gonadotropin beta unit
(hCGβ) antibody 2,764, alpha-fetoprotein (AFP) anti-
body IF5 and assay buffer, washing solution and hCGβ
and AFP-coated cups and calibrators were from the
DELFIA Xpress Free hCGβ and AFP Immunoassay
Kits (PerkinElmer). EDTA, CuSO4 and Triton X-100
were purchased from Aldrich.
Characterisation of the enhancement solutions
Fluorescence characteristics of the synthesised β-diketones
with Eu were tested in a glycine buffer at pH 2.3 containing
various concentrations of the water protecting agent TOPO
(25–120 μM), detergent Triton X-100 (0.05–0.2% v/v) and
the β-diketone (1–100 μM) to be tested. The concentrations
of the components of the enhancement solutions were
primarily optimised with respect to fluorescence intensity
of Eu, fluorescence signal stability, dissociation kinetics of
EuDTPA chelates and Eu(β-diketone)3 complex formation
velocity. Fluorescence intensity and analytical sensitivity
were determined by first diluting one volume of Eu
standard with nine volumes of the enhancement solution
to be tested, and then the obtained solution were serially
diluted with the enhancement solution. The fluorescence
from 200 μl of the serial dilutions of Eu standards was
measured in 96-well microtitration strip plates with a time-
resolved fluorometer (Victor D, PerkinElmer). Standard
dilutions of Sm, Tb and Dy were prepared and tested as
described for Eu in the enhancement solution with the most
intensive Eu fluorescence. The fluorescence from Tb and
Dy were measured after addition of 50 μl of dipicolinic
acid derivative (DELFIA Enhancer, PerkinElmer) to the
serially diluted standards. Instrument settings used are
shown in Table 1. Excitation and emission spectra for the
Table 1 Fluorescence of Eu and Sm in the BFPP-based enhancement solution
Fluorometer settings Fluorescence (n=4) Limit of blank
Lanthanide Excitation
filter (nm)
Emission
filter (nm)
Delay
time (μs)
Window
time (μs)
Cycle
time (μs)
Counts at
1 nmol/L
Background
Signal
Concentration
(fmol/L)
95% CI
Eu 340 615 400 400 1,000 1,112,000 113 40 30–64
Sm 340 642 50 100 1,000 6,092 62 2,100 1,610–3,370
Tb 340 545 500 1,400 2,000 571,300 825 130 86–181
Dy 340 572 30 30 1,000 8,824 350 8,500 6,310–13,200
Tb and Dy were measured after addition of dipicolinic acid
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measured with a PerkinElmer LS5 fluorescence spectrom-
eter. The velocity of fluorescent complex formation and the
stability of the fluorescence signal in the enhancement
solutions were determined by adding 5 μL of EuDTPA-
labelled AFP antibody and 195-μL enhancement solution
into microtitration plate wells that were shaken for 5 min at
room temperature and measuring the fluorescence as a
function of time. Enhancement solutions were stored in
dark at 4 °C and the fluorescence from 1 nmol/L of Eu in
the enhancement solution was measured at various time
points as described above.
Antibody labelling
Detector antibodies in these two assays were labelled
with europium chelate of 1-(4-isothiocyanatobenzyl)
diethylenetriamine-N,N,N′,N″,N″-pentaacetic acid. The an-
tibody at a concentration of 5 mg/mL was incubated with a
55-fold molar excess of the chelate in 50 mM carbonate
buffer pH 9.5 over night at 4 °C. Labelled antibody was
separated from unreacted chelates by gel filtration (Super-
dex 200, 1.6×60 cm, Pharmacia) with a buffer containing
50 mmol/L Tris–HCl, 9 g/L NaCl, pH 7.8, as eluation
buffer. When the ratio Eu/IgG was determined by
measuring the Eu concentration of conjugated antibody
against an Eu standard and the protein concentration with
absorbance, a conjugation level of ten was achieved. The
principle of protein labelling with bifunctional chelating
agents and coating of microtitration plates have in great
detail been described elsewhere [7].
Immunoassays
Blood samples were taken from volunteers into plain
tubes and EDTA-anticoagulant tubes. Informed consent
was obtained from all volunteers and the samples were
deidentified to ensure privacy. The study site has
obtained approval to conduct studies for research purpose
from the local ethical committee. The samples were
measured in duplicate on a DELFIAXpress® immunoa-
nalyzer (PerkinElmer). In the DELFIA, Xpress analyzer
sample (10 μL) and assay buffer (25 μL) are pipetted
simultaneously into anti-analyte antibody coated cups. In
5 μL, 50 ng of Eu-labelled detector antibody is added
and the cups are incubated with shaking at +35 °C for
20 min after which they are washed four times. The
fluorescence from the cups is measured after 100 μLo f
the developed enhancement solution was dispensed and
the cups incubated for 5 min at +35 °C. Antibody bound
Eu is dissociated from DTPA into the enhancement
solution in which it forms intensively fluorescent com-
plexes with the β-diketone. The effect of the complexone
EDTA and heavy metal Cu
2+ on the stability of the
detector molecule label EuDTPAwas also tested by adding
EDTA or Cu at various concentrations to the assay buffer
in order to get total concentrations in the assay mixture
ranging from 1–2 0 0m m o l / Lo fE D T Ao r0 –1,000 μmol/L
of Cu. The effect was tested with the analyzer at three
different hCGβ concentrations in duplicate, 236, 112 and
22 ng/mL.
Results
Fluorescence intensity and signal stability
Of all the β-diketones tested, the structure 1-(2-benzofuryl)-
4,4,5,5,5-pentafluoro-1,3-pentanedione (BFPP) had the most
favourable properties with respect to fluorescence intensity,
analytical sensitivity, complex formation kinetics and signal
stability in a glycine buffer at pH 2.3 with 50 μMT O P Oa n d
0.2% (v/v) Triton X-100. This enhancement solution disso-
ciates the lanthanide ions from LnDTPA and forms in 5 min
an intensively fluorescing complex between BFPP and
lanthanide. Once the Ln(BFPP)3 complex is formed, the
signal is stable for several hours in the solution (Table 2.)
and the enhancement solution itself is stable upon storage at
+4 °C for at least 18 months (Table 3).
Spectra
Excitation and emission spectra for the lanthanides are
depicted in Fig. 1. All four lanthanides emit at one principal
wavelength and the emission peaks are narrow and well
separated from each other.
Limit of blank and dynamic range
The limit of blank (mean+3SD with 95% CI) for Eu in
developed enhancement solution, 40 (30–64) fmol/L, is of
the same order of magnitude than that of DELFIA
enhancement solution, 80 (115–200) fmol/L. The lowest
Table 2 Kinetics of fluorescent complex formation in the BFPP-
based fluorescence enhancement solution at RT
Incubation time (min) Fluorescence (counts, 10
3) CV% (n=3)
5 1,800 4.5
15 1,850 4.2
30 1,853 4.0
60 1,858 4.4
120 1,869 4.7
240 1,849 4.7
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Dy (Table 1). In the developed enhancement solution the
relationship between the Ln concentration and the fluores-
cent signal is linear up to 10 nmol/L of La and the
fluorometer is linear up to 5×10
6 fluorescence counts with
the instrument settings shown in Table 1. These character-
istics result in a dynamic range that is about 5 logs for Eu
and Tb and 4 logs for Sm and Dy, respectively.
Effect of edta plasma and metal ions
In immunoassays of hCGβ and AFP the regression
equations show no difference in the measured concentration
levels between serum and EDTA plasma samples, indicat-
ing that the EuDTPA chelate conjugated to the detector
antibody is stable and withstands the chelating effect of
EDTA in plasma samples (Fig. 2). When EDTA was added
to the reaction mixture in an assay of serum hCGβ the
signal is stable up to 100 mmol/L of EDTA for all three
hCGβ concentration levels measured. In an assay of hCGβ
in serum samples, the measured concentrations are un-
changed with up to 200 μmol/L Cu
2+ present at three
different hCGβ concentrations (Fig. 3). The criterion for
stability was the P value for the slopes from the regression
analysis of EDTA or Cu
2+ concentrations present vs. the
response in the hCGβ assay for all three hCGβ concen-
trations tested. We concluded that if P>0.05, the slopes
were not significantly different from zero, and hence there
were no evidence for dissociation of Eu from the labelled
antibody.
Discussion
In dissociative fluorescence enhancement techniques rely-
ing on lanthanide probes, the fluorescence is measured in
an enhancement solution after completion of the biospecific
reaction. Immunoassays using this technique are usually
performed on microtitration plates in which bound and free
tracer is separated by washing and the fluorescence of the
bound fraction (solid phase) is measured after addition of
enhancement solution to the wells of the plates. An
enhancement solution useful for routine laboratory applica-
tions is characterized by an intensive fluorescence (absorp-
tivity×quantum yield), wide dynamic range, rapid
dissociation in the enhancement solution of the lanthanide
ions from the chelates that are conjugated to detector
molecules, fast formation of fluorescent Ln complexes with
the components of the enhancement solution, a stable
fluorescence signal and long storage stability.
The enhancement solution and diethylenetriaminetetra
acetate (DTTA) chelates used in the DELFIA technology
meet these criteria to a high degree. In the enhancement
solution of this technology, lanthanide ions rapidly disso-
ciate from the DTTA chelates due low pH (3.2). Eu and Sm
form a fluorescent complex with the light absorbing
trifluorinated β-diketone 2-naphtoyltrifluoroacetone (2-
NTA). Lanthanide chelates of DTTA are stable in a reaction
mixture not containing strong complexones such as EDTA
and dissociate and form highly fluorescent 2-NTA com-
plexes in less than 5 min in the enhancement solution.
In immunoassays intended for the clinical laboratory the
main limitation of the present DELFIA technique is that
citrate and EDTA plasma samples cannot be used in one-
step assay formats since Ln ions may dissociate from
DTTA at these conditions.
In this study the goal was to develop a variant of the
dissociative enhancement technique that is robust and fast
Fig. 1 Excitation and emission spectra for Eu, Sm, Tb and Dy. The
spectra for Eu (red) and Sm (dark red) were measured in the BFPP-
based enhancement solution. Excitation maxima, emission maxima and
decay times obtained were 354 nm, 614 nm and 570 μs for Eu and
353 nm, 643 nm and 43 μs for Sm, respectively. The spectra for Tb
(green) and Dy (orange) were determined after addition of dipicolinic
acid to the BFPP enhancement solution. Excitation maxima, emission
maxima and decay times for Tb were 319 nm, 544 nm and 1,190 μs
and for Dy 317 nm, 572 nm and 20 μs, respectively
Table 3 Storage stability of the BFPP-based enhancement solution at
+4 °C
Storage time (days) Fluorescence (counts, 10
3) CV% (n=6)
0 1,252 0.9
6 1,316 1.9
13 1,256 1.1
27 1,237 0.9
41 1,263 1.1
83 1,263 0.3
178 1,259 0.2
345 1,158 0.3
539 1,267 0.6
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ions at concentrations interfering with LnDTTA chelates.
The interference from complexones and metal ions in the
biospecific reaction mixture can be avoided by replacing
LnDTTA with chelates possessing a higher stability. DTPA
chelates of Ln withstand the citrate and EDTA in plasma
samples due to a high stability constant (K=10
23)[ 15], but
the drawback is the slow dissociation at pH>3.0 (120 min)
[16], the lowest pH at which for instance 2-NTA-based
enhancements work. The complex formation between Ln
ions and 2-NTA is incomplete at lower pH. A long
dissociation and complex formation time is unpractical in
the laboratory and makes automation difficult. Therefore, a
2-NTA-based enhancement solution together with LnDTPA
conjugates is not the best of choices.
A number of potential β-diketones were screened for their
complex formation ability with Ln at pH values below 3.
Acidic conditions increase the dissociation of LnDTPA
chelates as the equilibrium is towards protonated DTPA and
an excess of β-diketone further shifts the equilibrium towards
Ln-β-diketone complexes The β-diketones investigated have
three essential features: a light absorbing aryl group, two
ketonegroupsthatbindstothecoordinationsitesoftheLnion
and a fluorinated alkyl group that shifts the ketone-enole
equilibrium towards the enole form. Five or seven strongly
electronegative fluorine atoms make these β-diketones more
acidic than 2-NTAwith three fluorine atoms. These properties
ensure efficient absorption of light upon excitation and
complex formation at low pH. Of all the candidate β-
diketones tested, the characteristics of BFPP met the require-
ments best. The benzofuryl group absorbs excitation light
efficiently and the pentafluorinated alkyl group shifts the
equilibrium towards the enole form also at low pH, which
facilitates complex formation with Eu. The developed
enhancement solution was primarily optimised for Eu
detection and contains BFPP, TOPO and Triton X-100 in a
glycine buffer at pH 2.3. Also, Sm fluoresces strongly in this
solution. The synergistic agent TOPO and the micelle-
forming detergent Triton X-100 further protects the Ln
(BFPP)3 complex from fluorescence quenching water mol-
ecules by replacing them at remaining coordination sites in
Fig. 3 Effect of EDTA and Cu
2+ on the stability of the EuDTPA
derivative used for detector antibody labelling in the hCGβ assay. a
The P value was >0.05 for up to 100 mmol/L EDTA for all three
hCGβ concentrations tested (from the highest to the lowest signal
level, P=0.68 (circles); P=0.07 (squares); P=0.67 (triangles)). b The
P value was >0.05 for up to 200 μmol/L Cu
2+ for all three hCGβ
concentrations tested (from the highest to the lowest signal level, P=
0.11 (circles); P=0.27 (squares); P=0.42 (triangles))
Fig. 2 Linear regression analy-
sis of serum and EDTA plasma
samples analysed for hCGβ and
AFP using a one-step assay
format. Concentration level dif-
ference between the two sample
types was not observed. a hCGβ
assay, y=1.001×−0.16; y/x=
0.329; n=22; r=0.998. b AFP
assay, y=0.958×+0.611; y/x=
5.990; n=26; r=0.996
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LnDTPA chelates dissociate rapidly in this solution. Dipico-
linic acid derivative at neutral pH is a better fluorescence-
enhancing ligand than BFPP for Tb and Dy because of its
higher excited triplet state energy level. In quadruple label
assays Eu and Sm are measured in the BFPP-based
enhancement solution subsequent to the completion of the
biospecific reaction and the fluorescence of the dissociated
Tb and Dy are detected after addition of a dipicolinic acid
derivative containing solution that raises the pH to neutral.
The fluorescenceintensities ofEuandSm inthe developed
enhancement solution as well as the achieved analytical
sensitivities compare well with the established 2-NTA-based
enhancement solutions. Tb and Dy can be detected after
addition ofdipicolinic acid. The dynamic range for Eu and Tb
is about 5 logs and for Sm and Dy 4 logs, which is identical to
the dynamic range for 2-NTA-based DELFIA enhancement
solution. Most of the fluorescence is emitted at one
wavelength as a narrow peak and all four lanthanides emit at
different wavelengths. They can be distinguisted from each
other, due to the favourable spectra (spectral resolution) and
by utilising their different fluorescence decay times for
temporal resolution i.e. employing different delay times when
measuring the lanthanides. This permits quadruple-plex
assays to be designed, although overlapping spectra must be
accounted for and corrected for when detecting Sm in wells
with high Eu concentrations and Dy in prescence of high Tb
concentrations. The assay requiring the lowest limit of
detection should be labelled with Eu, followed by Tb, Sm
and Dy. Usually up to 20 DTPA chelates can be conjugated to
an antibody without any severe effects on the affinity which
makes it easy to set up sandwich immunoassays that work in
the picomolar range. In the assays for hCGβ and AFP the
detector antibodies were labelled with an isothiocyanate
derivative of DTPA which reacts with amino groups. SH and
COO groups can be labelled with iodoacetamido and amino
derivatives of DTPA, respectively. There is no dissociation of
E uf r o mD T P Aa t3 5° Ci na nas s a ym i xt u r ew i t hh um a ns er u m
containing EDTA, nor is any dissociation observed with
200 μMo fC u
2+ present, showing that this enhancement
technique can be used in one-step assays containing complex-
ones or metal ions, and at physiological temperatures.
The presented fluorescence enhancement technique for
bioanalytical assays offers advantages over current techni-
ques, such as, one-step assays with EDTA and other plasma
samples containing complexones as anti-coagulants, lan-
thanide labelling chelate stability at high concentrations of
metal ions and at elevated temperatures, important in some
DNA hybridisation assays as well as some enzymatic
assays and rapid immunoassays. Four response parameters
can be measured from the same assay mixture with the
presented technique. The lanthanides are chelated to DTPA
which is stable at a vast range of assay condition resulting
in that one chelate structure works for almost all assay
designs and applications. Automation is easier with the
improved fluorescence enhancement technique due to fewer
steps and hence shorter assay protocols.
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